"On April 30, the Centers for Medicare and Medicaid Services (CMS) promulgated a second interim final rule with comment period (IFC) and additional waivers to ensure the healthcare system can respond to the public health threats posed by COVID-19. The changes in this IFC address issues raised by the first IFC, support the expansion of testing, improve access to telehealth services, and reduce the regulatory burden on providers."
Read the Full Summary 
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.
